Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11479556 Bifunctional compounds for degrading BTK via ubiquitin proteosome pathway

Patent 11479556 was granted and assigned to Nurix Therapeutics on October, 2022 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Applicant

Nurix Therapeutics

Current Assignee

Nurix Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Date of Patent

October 25, 2022

Patent Application Number

15734774

Date Filed

October 14, 2019

Patent Citations

US Patent 10415015 Engineered artificial antigen presenting cells for tumor infiltrating lymphocyte expansion

US Patent 10420799 Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

US Patent 10463697 Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

US Patent 10517894 Restimulation of cryopreserved tumor infiltrating lymphocytes

US Patent 10537595 Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

US Patent 10639330 Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

US Patent 10646517 Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

US Patent 10653723 Processes for production of tumor infiltrating lymphocytes and uses of the same in immunotherapy

...

Patent Citations Received

US Patent 11866442 Bifunctional compounds for degrading BTK via ubiquitin proteosome pathway

0

Patent Primary Examiner

Samantha L Shterengarts

The present invention relates to compounds useful for degrading BTK via a ubiquitin proteolytic pathway. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11479556 Bifunctional compounds for degrading BTK via ubiquitin proteosome pathway

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.